Cohortias – Positive data from Alzheimer’s disease vaccine trial
At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.
Cohortias – Phase I for new ulcerative colitis therapy trial
ALTB-268 helps to restore the immune system to a state of balance.
Cohortias – FDA clears to begin colorectal cancer therapy trial
The trial will enroll 44 patients who are failing prior lines of chemotherapy and who express LGR5 on cancer cells.
Cohortias – New trial for lung disease treatment
The trial will assess the efficacy and safety of pulsed inhaled nitric oxide in patients at risk for pulmonary hypertension.
Cohortias – Phase II trial of nasal spray therapy for Hyposmia
The trial is expected to enroll subjects at 20 clinical sites in the US and will assess CYR-064 for six months.
Cohortias – When will the new vaccine to prevent herpes zoster be available in Argentina?
Shingrix shingles vaccine was 90% effective in preventing viral infection in adults over 50 years of age
Cohortias – ‘Incurable’ Fatal Syndrome May Finally Be Treated By New Drug
At the moment there's no known cure for it, but scientists have now identified a potentially effective treatment
Cohortias – First data report from study of rare prostate cancer therapy
The trial assessed the efficacy and safety of BXCL701 along with pembrolizumab in SCNC patients.
Cohortias – Mexican pharma market growth factors and advantages
Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages.
Cohortias – Anvisa analyzes application for registration of dengue vaccine
The purpose of the meeting is to clarify technical doubts and have access to preliminary data.